Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Identify the cheapest index funds for retirement in 2024 and learn how fees impact long-term growth with a practical buying guide.
23,813 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A robust May jobs report sent U.S. stocks lower as investors weighed inflation risks and policy paths. Barclays warns...
Bitcoin gave up weekend gains as oil surged and geopolitical tensions in the Middle East intensified, signaling renew...
Last month, poet technologies skyrocketed 72.6%, delivering a dramatic rally in a volatile sector. This article expla...
Investors are watching Duluth Trading closely as the Q1 2026 earnings cycle begins. This in-depth look breaks down wh...
U.S. equities sit near record highs as AI spending fuels gains, but a growing chorus on Wall Street warns that federa...
A steep rally has many investors wondering if Intel is a steal or a trap. This guide breaks down the 168% swing in 20...
Promotional sign up offers can turbocharge your rewards, but they’re easy to misread. This expert guide breaks down h...
James Harris’s lean, quality-first model propelled Harris & Partners to No. 2 among large teams in the 2026 RealTrend...
Bloom Energy stock plunged more than 10% on a single trading day, leaving investors wondering if the pullback marks a...
Anthropic unveils a $150 million fellowship to place 1,000 AI coaches with nonprofits for a year, funded as the compa...
Buffini & Company hires three senior leaders to accelerate its referral-based coaching model in a rapidly evolving AI...